Faecal Calprotectin

Faecal Calprotectin is a national collaborative project.

The project is based around the measurement of calprotectin in the stool; elevated calprotectin indicates intestinal inflammation, possibly caused by inflammatory bowel disease, such as Crohn’s disease and ulcerative colitis. The use of such a test allows GPs to distinguish between irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD). This potentially avoids the patient being referred to secondary care and reducing the amount of invasive colonoscopy being performed. Rolled out nationally, this programme has the potential to ultimately affect 322,000 patients a year and save £15m of NHS costs over 2 years.

Yorkshire and Humber AHSN has recently published a research paper evaluating the York Faecal Calprotectin Care Pathway.

You can find out more about the Faecal Calprotectin Pathway on the AHSN Network’s ATLAS.

Delivery across the NENC

THE AHSN NENC is keen to expand the Faecal Calprotectin pathway in our locality working with our STP/ICS and the Northern Cancer Alliance.